{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:38:09Z","timestamp":1773963489758,"version":"3.50.1"},"posted":{"date-parts":[[2025,1,22]]},"group-title":"Public and Global Health","reference-count":51,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,1,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Overdoses are a leading cause of maternal mortality in the US, but limited evidence exists about patterns of nonfatal overdose, a key risk factor for subsequent fatal overdose, or of other drug-related harms. Here, we estimate prevalences of nonfatal overdose and injection-related endocarditis and abscesses\/cellulitis across the 21 months spanning pregnancy and the postpartum year.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Among people who experienced an in-hospital birth in New York State between 9\/1\/2016 and 1\/1\/2018 (N=330,872), we estimated the prevalences of hospital-based diagnoses of nonfatal overdose and of injection-related bacterial infections (i.e., endocarditis, abscesses, and cellulitis) across these 21 months; by trimester and postpartum quarter; and by social position (e.g., race\/ethnicity, rurality, payor).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 21-month nonfatal overdose prevalence was 158\/100,000 births (CI: 145\/100,000, 172\/100,000); the 21-month prevalence of injection-related bacterial infections was 56\/100,000 births (CI: 49\/100,000, 65\/100,000). There was a trend such that rates of overdose and of injection-related bacterial infections declined as pregnancy progressed and rebounded postpartum. Rates of all outcomes were highest outside of large metropolitan areas and among publicly insured residents.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions for Practice<\/jats:title>\n                  <jats:p>The trend toward diminished rates during pregnancy is supported by past qualitative studies. If confirmed by future research in other geographical regions and with larger sample sizes, this finding holds promise for programmatic and policy interventions. Interventions co-designed with people who use drugs could complement and support harm reduction efforts that pregnant people are already engaging in independently. Such efforts can help people who use drugs survive the pregnancy and postpartum year.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>\u201cWhat is already known on this subject?<\/jats:p>\n                  <jats:p>Fatal overdoses are a leading cause of maternal mortality in the US. Little evidence exists, however, about patterns of nonfatal overdose, a strong predictor of future fatal overdose, or about other serious injection-related bacterial infections.<\/jats:p>\n                  <jats:p>\u201cWhat this study adds?<\/jats:p>\n                  <jats:p>We find trends suggesting that rates of nonfatal overdose and injection-related bacterial infections decline during pregnancy and then rebound postpartum. These findings, if confirmed in future research, suggest a clear path toward intervention development: partnering with people who use drugs to design interventions that complement and support their existing harm reduction interventions during pregnancy and in the postpartum period.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.01.21.25320879","type":"posted-content","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T13:15:19Z","timestamp":1737551719000},"source":"Crossref","is-referenced-by-count":3,"title":["Patterns of non-fatal overdose and injection-related bacterial infections during pregnancy and the postpartum year among New York State residents"],"prefix":"10.64898","author":[{"given":"Hannah LF","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan R.","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Wien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"10","key":"2025012400500468000_2025.01.21.25320879v1.1","first-page":"1","article-title":"Pregnancy-related deaths: data from maternal mortality review committees in 36 US states, 2017\u20132019","volume":"45","year":"2022","journal-title":"Education"},{"key":"2025012400500468000_2025.01.21.25320879v1.2","first-page":"1","article-title":"Maternal mortality and maternity care in the United States compared to 10 other developed countries","volume":"10","year":"2020","journal-title":"The Commonwealth Fund"},{"key":"2025012400500468000_2025.01.21.25320879v1.3","doi-asserted-by":"crossref","unstructured":"Cooper HL , Rice W , Cummings J , Livingston MD , Peddireddy S , Rogers E , et al. Overdoses, Reproductive Justice, and Harm Reduction. American Public Health Association; 2023. p. 933\u20135.","DOI":"10.2105\/AJPH.2023.307379"},{"key":"2025012400500468000_2025.01.21.25320879v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.02.056"},{"key":"2025012400500468000_2025.01.21.25320879v1.5","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/QAI.0000000000000625","article-title":"Bringing female substance users to the center of the global HIV response","volume":"69","year":"2015","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"2025012400500468000_2025.01.21.25320879v1.6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40141-019-00247-2","article-title":"Neurologic, cognitive, and behavioral consequences of opioid overdose: a review","volume":"7","year":"2019","journal-title":"Current Physical Medicine and Rehabilitation Reports"},{"key":"2025012400500468000_2025.01.21.25320879v1.7","doi-asserted-by":"crossref","unstructured":"Gan WQ , Buxton JA , Palis H , Janjua NZ , Scheuermeyer FX , Xavier CG , et al. Drug overdose and the risk of cardiovascular diseases: a nested case\u2013control study. Clinical Research in Cardiology. 2021:1\u201310.","DOI":"10.1007\/s00392-021-01945-5"},{"issue":"6","key":"2025012400500468000_2025.01.21.25320879v1.8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/10826084.2022.2046100","article-title":"Miscarriage and abortion among women attending harm reduction services in Philadelphia: correlations with individual, interpersonal, and structural factors","volume":"57","year":"2022","journal-title":"Substance use & misuse"},{"issue":"1","key":"2025012400500468000_2025.01.21.25320879v1.9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amepre.2020.02.012","article-title":"Mortality following nonfatal opioid and sedative\/hypnotic drug overdose","volume":"59","year":"2020","journal-title":"American journal of preventive medicine"},{"key":"2025012400500468000_2025.01.21.25320879v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa149"},{"issue":"6","key":"2025012400500468000_2025.01.21.25320879v1.11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.wombi.2020.01.006","article-title":"The labor and birth experience of women with opioid use disorder: a qualitative study","volume":"33","year":"2020","journal-title":"Women and Birth"},{"key":"2025012400500468000_2025.01.21.25320879v1.12","unstructured":"Boyd SC . Mothers and illicit drugs: transcending the myths: Arts and Social Sciences: Criminology; 1996."},{"issue":"3","key":"2025012400500468000_2025.01.21.25320879v1.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J233v05n03_01","article-title":"The elusive romance of motherhood:drugs, gender, and reproduction in inner-city distressed households","volume":"5","year":"2006","journal-title":"J Ethn Subst Abuse"},{"key":"2025012400500468000_2025.01.21.25320879v1.14","doi-asserted-by":"publisher","DOI":"10.1177\/0891241602238937"},{"key":"2025012400500468000_2025.01.21.25320879v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.childyouth.2008.05.011"},{"key":"2025012400500468000_2025.01.21.25320879v1.16","doi-asserted-by":"publisher","DOI":"10.1177\/104973299129122117"},{"key":"2025012400500468000_2025.01.21.25320879v1.17","doi-asserted-by":"publisher","DOI":"10.1177\/002204269802800105"},{"key":"2025012400500468000_2025.01.21.25320879v1.18","doi-asserted-by":"publisher","DOI":"10.1086\/522176"},{"key":"2025012400500468000_2025.01.21.25320879v1.19","doi-asserted-by":"crossref","unstructured":"DesBiens MT , de Gijsel D , Chan BP , Talbot EA , Conn S , Laflamme D , editors. 140. Trends of Infective Endocarditis at a Northern New England Academic Medical Center, From 2011 to 2017: A Case for Improved Methods to Reliably Identify Associated Substance Use. Open Forum Infectious Diseases; 2019: Oxford University Press US.","DOI":"10.1093\/ofid\/ofz360.215"},{"key":"2025012400500468000_2025.01.21.25320879v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.011"},{"issue":"8","key":"2025012400500468000_2025.01.21.25320879v1.21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/23744235.2021.1912821","article-title":"Infective endocarditis in pregnancy from 2009 to 2019: the consequences of injection drug use","volume":"53","year":"2021","journal-title":"Infectious Diseases"},{"issue":"9","key":"2025012400500468000_2025.01.21.25320879v1.22","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/cid\/ciab533","article-title":"Maternal and fetal outcomes associated with infective endocarditis in pregnancy","volume":"73","year":"2021","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"2025012400500468000_2025.01.21.25320879v1.23","doi-asserted-by":"crossref","first-page":"e0235350","DOI":"10.1371\/journal.pone.0235350","article-title":"Prevalence and severity of abscesses and cellulitis, and their associations with other health outcomes, in a community-based study of people who inject drugs in London, UK","volume":"15","year":"2020","journal-title":"Plos one"},{"key":"2025012400500468000_2025.01.21.25320879v1.24","doi-asserted-by":"publisher","DOI":"10.1086\/313703"},{"issue":"6","key":"2025012400500468000_2025.01.21.25320879v1.25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/ADM.0000000000000346","article-title":"Risk factors associated with skin and soft tissue infections among hospitalized people who inject drugs","volume":"11","year":"2017","journal-title":"Journal of addiction medicine"},{"key":"2025012400500468000_2025.01.21.25320879v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.12.968"},{"issue":"2","key":"2025012400500468000_2025.01.21.25320879v1.27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/JNC.0000000000000016","article-title":"Association of self-reported abscess with high-risk injection-related behaviors among young persons who inject drugs","volume":"30","year":"2019","journal-title":"Journal of the Association of Nurses in AIDS Care"},{"key":"2025012400500468000_2025.01.21.25320879v1.28","doi-asserted-by":"crossref","unstructured":"Kariisa M . Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics\u201425 states and the District of Columbia, 2019\u20132020. MMWR Morbidity and mortality weekly report. 2022;71.","DOI":"10.15585\/mmwr.mm7129e2"},{"key":"2025012400500468000_2025.01.21.25320879v1.29","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002734"},{"key":"2025012400500468000_2025.01.21.25320879v1.30","unstructured":"CDC. Maternal Mortality by State, 2018 Atlanta, GA: CDC; ND [Available from: https:\/\/www.cdc.gov\/nchs\/maternal-mortality\/MMR-2018-State-Data-508.pdf."},{"issue":"Suppl 1","key":"2025012400500468000_2025.01.21.25320879v1.31","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1136\/injuryprev-2019-043520","article-title":"Descriptive exploration of overdose codes in hospital and emergency department discharge data to inform development of drug overdose morbidity surveillance indicator definitions in ICD-10-CM","volume":"27","year":"2021","journal-title":"Injury prevention"},{"key":"2025012400500468000_2025.01.21.25320879v1.32","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1009213286"},{"issue":"10","key":"2025012400500468000_2025.01.21.25320879v1.33","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/MLR.0000000000000838","article-title":"Validation of an algorithm to identify infective endocarditis in people who inject drugs","volume":"56","year":"2018","journal-title":"Medical care"},{"issue":"2","key":"2025012400500468000_2025.01.21.25320879v1.34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/ADM.0000000000000093","article-title":"High rates of abscesses and chronic wounds in community-recruited injection drug users and associated risk factors","volume":"9","year":"2015","journal-title":"Journal of addiction medicine"},{"key":"2025012400500468000_2025.01.21.25320879v1.35","doi-asserted-by":"crossref","unstructured":"Gonsalves GS , David Paltiel A , Thornhill T , Iloglu S , DeMaria Jr A , Cranston K , et al., editors. The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts. Open Forum Infectious Diseases; 2021: Oxford University Press US.","DOI":"10.1093\/ofid\/ofab128"},{"issue":"3","key":"2025012400500468000_2025.01.21.25320879v1.36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugpo.2005.03.001","article-title":"Police drug crackdowns and hospitalisation rates for illicit-injection-related infections in New York City","volume":"16","year":"2005","journal-title":"International Journal of Drug Policy"},{"key":"2025012400500468000_2025.01.21.25320879v1.37","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05352-z"},{"key":"2025012400500468000_2025.01.21.25320879v1.38","doi-asserted-by":"crossref","unstructured":"Alkhouli M , Alqahtani F , Alhajji M , Berzingi CO , Sohail MR , editors. Clinical and economic burden of hospitalizations for infective endocarditis in the United States. Mayo Clinic Proceedings; 2020: Elsevier.","DOI":"10.1016\/j.mayocp.2019.08.023"},{"issue":"1","key":"2025012400500468000_2025.01.21.25320879v1.39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.surge.2014.08.003","article-title":"Ricketts D. A comparative analysis of the patient characteristics and cost of managing intravenous drug users (IVDU) with soft tissue abscesses with non-IVDU","volume":"14","year":"2016","journal-title":"the surgeon"},{"key":"2025012400500468000_2025.01.21.25320879v1.40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.annepidem.2024.04.007","article-title":"Person-centered hospital discharge data: Essential existing infrastructure to enhance public health surveillance of maternal substance use disorders in the midst of a national maternal overdose crisis","volume":"94","year":"2024","journal-title":"Annals of epidemiology"},{"issue":"2","key":"2025012400500468000_2025.01.21.25320879v1.41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: a US nationwide small area analysis","volume":"24","year":"2021","journal-title":"Value in Health"},{"issue":"48","key":"2025012400500468000_2025.01.21.25320879v1.42","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","article-title":"Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013","volume":"64","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025012400500468000_2025.01.21.25320879v1.43","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS): 2020. Data on Substance Abuse Treatment Facilities. Rockville, MD: DHHS; 2021."},{"key":"2025012400500468000_2025.01.21.25320879v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108127"},{"issue":"2","key":"2025012400500468000_2025.01.21.25320879v1.45","first-page":"286","article-title":"Poverty and biological risk: the earlier \u201caging\u201d of the poor","volume":"64","year":"2009","journal-title":"Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences"},{"issue":"4","key":"2025012400500468000_2025.01.21.25320879v1.46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/0167482X.2019.1689949","article-title":"Trends in mental health and substance use disorders and treatment receipt among pregnant and nonpregnant women in the United States, 2008\u20132014","volume":"41","year":"2020","journal-title":"Journal of Psychosomatic Obstetrics & Gynecology"},{"key":"2025012400500468000_2025.01.21.25320879v1.47","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.21040381"},{"key":"2025012400500468000_2025.01.21.25320879v1.48","doi-asserted-by":"crossref","first-page":"107652","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: Motivators and barriers","volume":"205","year":"2019","journal-title":"Drug and alcohol dependence"},{"key":"2025012400500468000_2025.01.21.25320879v1.49","unstructured":"Knight KR. Addicted. pregnant. poor: Duke University Press; 2015."},{"key":"2025012400500468000_2025.01.21.25320879v1.50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2019.12.005","article-title":"Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings","volume":"110","year":"2020","journal-title":"Journal of substance abuse treatment"},{"issue":"5","key":"2025012400500468000_2025.01.21.25320879v1.51","first-page":"939","volume":"59","year":"2023","journal-title":"Infective endocarditis during pregnancy\u2014keep it safe and simple! Medicina"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.01.21.25320879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:26:02Z","timestamp":1768508762000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.01.21.25320879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1101\/2025.01.21.25320879","relation":{},"subject":[],"published":{"date-parts":[[2025,1,22]]},"subtype":"preprint"}}